1. Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
   Li Lin et al, 2023, Frontiers in Oncology CrossRef
2. Current status of molecular diagnostics for lung cancer
   Evgeny N. Imyanitov et al, 2024, Exploration of Targeted Anti-tumor Therapy CrossRef
3. Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
   Esha Vallabhaneni et al, 2024, Cancers CrossRef
4. The rapidly changing field of predictive biomarkers of non-small cell lung cancer
   László József Tóth et al, 2024, Pathology and Oncology Research CrossRef
5. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications
   Juan Carlos Laguna et al, 2024, British Journal of Cancer CrossRef
6. A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations
   Iacopo Petrini et al, 2024, Clinical Lung Cancer CrossRef